Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Rajkumar

Showing results (71-80 of 773) with videos related to

Pageof 78
Sort By:
Nature Reviews. Clinical Oncology|March 10, 2019
MAIA under the microscope - bringing trial design into focusPrashant Kapoor, S Vincent Rajkumar
The New England Journal of Medicine|October 1, 2025
Monoclonal Gammopathy of Undetermined SignificanceS Vincent Rajkumar, Shaji Kumar
Mayo Clinic Proceedings|March 21, 2015
Why are cancer drugs so expensive in the United States, and what are the solutions?Hagop Kantarjian, S Vincent Rajkumar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Why not start with thalidomide?Charles Loprinzi, S Vincent Rajkumar
Nature Reviews. Clinical Oncology|January 11, 2017
Multiple myeloma in 2016: Fresh perspectives on treatment and moments of clarityPrashant Kapoor, S Vincent Rajkumar
Mayo Clinic Proceedings|March 16, 2013
In replyMustaqeem Siddiqui, S Vincent Rajkumar
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2007
Renal manifestations of plasma cell disordersNelson Leung, S Vincent Rajkumar
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Smoldering Multiple Myeloma: To Treat or Not to TreatPrashant Kapoor, S Vincent Rajkumar
Leukemia|July 23, 2025
Current risk stratification and staging of multiple myeloma and related clonal plasma cell disordersSaurabh Zanwar, S Vincent Rajkumar
Blood Reviews|September 2, 2023
Current approach to Waldenström macroglobulinemiaPrashant Kapoor, S Vincent Rajkumar
Pageof 78

Showing results (71-80 of 773) with videos related to

Sort By:
Pageof 78
Nature Reviews. Clinical Oncology|March 10, 2019
MAIA under the microscope - bringing trial design into focusPrashant Kapoor, S Vincent Rajkumar
The New England Journal of Medicine|October 1, 2025
Monoclonal Gammopathy of Undetermined SignificanceS Vincent Rajkumar, Shaji Kumar
Mayo Clinic Proceedings|March 21, 2015
Why are cancer drugs so expensive in the United States, and what are the solutions?Hagop Kantarjian, S Vincent Rajkumar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Why not start with thalidomide?Charles Loprinzi, S Vincent Rajkumar
Nature Reviews. Clinical Oncology|January 11, 2017
Multiple myeloma in 2016: Fresh perspectives on treatment and moments of clarityPrashant Kapoor, S Vincent Rajkumar
Mayo Clinic Proceedings|March 16, 2013
In replyMustaqeem Siddiqui, S Vincent Rajkumar
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 27, 2007
Renal manifestations of plasma cell disordersNelson Leung, S Vincent Rajkumar
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Smoldering Multiple Myeloma: To Treat or Not to TreatPrashant Kapoor, S Vincent Rajkumar
Leukemia|July 23, 2025
Current risk stratification and staging of multiple myeloma and related clonal plasma cell disordersSaurabh Zanwar, S Vincent Rajkumar
Blood Reviews|September 2, 2023
Current approach to Waldenström macroglobulinemiaPrashant Kapoor, S Vincent Rajkumar
Pageof 78